SKI Market

A+| A| A-|

Indian Indices

Sensex

77,054.94 -561.46
( -0.72%)

Global Indices

Nasdaq

52,524.20 -133.81
(-0.25%)

Dow Jones

7,536.77 -59.62
(-0.78%)

Hang Seng

67,669.68 426.95
(0.63%)

Nikkei 225

10,519.19 20.90
(0.20%)

Forex

USD-INR

95.25 -0.20
(-0.21%)

EUR-INR

108.70 -0.40
(-0.37%)

GBP-INR

127.58 -0.36
(-0.28%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0470742

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

18.94

114205.26

EPS(TTM)

Face Value()

Div & Yield %

131.91

0.72

Back

Integra Engineering India consolidated net profit declines 17.43% in the March 2026 quarter

May 20,2026

Net profit of Integra Engineering India declined 17.43% to Rs 3.41 crore in the quarter ended March 2026 as against Rs 4.13 crore during the previous quarter ended March 2025. Sales declined 5.99% to Rs 39.73 crore in the quarter ended March 2026 as against Rs 42.26 crore during the previous quarter ended March 2025.

For the full year,net profit declined 16.60% to Rs 15.42 crore in the year ended March 2026 as against Rs 18.49 crore during the previous year ended March 2025. Sales rose 1.72% to Rs 168.71 crore in the year ended March 2026 as against Rs 165.86 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	39.73	42.26	-6	168.71	165.86	2
OPM %	15.93	18.27	-	16.91	18.98	-
PBDT	5.92	7.00	-15	26.71	30.03	-11
PBT	4.71	5.93	-21	21.86	26.40	-17
NP	3.41	4.13	-17	15.42	18.49	-17

77,054.94 -561.46 ( -0.72%)

52,524.20 -133.81 (-0.25%)

7,536.77 -59.62 (-0.78%)

67,669.68 426.95 (0.63%)

10,519.19 20.90 (0.20%)

95.25 -0.20 (-0.21%)

108.70 -0.40 (-0.37%)

127.58 -0.36 (-0.28%)

0.59 0.00 (0.19%)